| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,600 | 3,822 | 3,631 | 2,998 | | Cost of Revenue | 344 | 431 | 348 | 167 | | | Gross Profit | 3,256 | 3,391 | 3,283 | 2,831 | | | Operating Expenses | | Research Development | 8,123 | 7,746 | 8,312 | 10,646 | | Selling General and Administrative | 7,982 | 6,940 | 6,542 | 6,324 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (12,849) | (11,295) | (11,571) | (14,139) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 29 | 35 | 76 | 271 | | Earnings Before Interest And Taxes | (12,820) | (11,260) | (11,495) | (13,868) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (12,820) | (11,260) | (11,495) | (13,868) | | Income Tax Expense |
-
|
-
| (194) |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,820) | (11,260) | (11,301) | (13,868) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,820) | (11,260) | (11,301) | (13,868) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,820) | ($11,260) | ($11,301) | ($13,868) |
|
0.51% Nasdaq 
Income Statement
